Carcinogenesis, Vol. 24, No. 2, 335-342,
February 2003
© 2003 Oxford University Press
CANCER BIOLOGY |
Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice
1 First Department of Pathology, Osaka City University Medical School, 1-4-3-Asahi-machi, Abeno-Ku, Osaka 545-8585, Japan,
2 Department of Zoology, Faculty of Science, Tanta University, Laboratory of Experimental and Molecular Carcinogenesis, Tanta 31527, Egypt and
3 Department of Preventive Medicine and Environmental Health. Osaka City University Medical School, Osaka, Japan
There is abundant epidemiological evidence that arsenic is an environmental carcinogen related to human cancers of the skin, lung, liver and urinary bladder, in particular. Dimethylarsinic acid (DMA) has also been reported to act as a carcinogen/or a promoter in rat models. To elucidate molecular mechanisms, we conducted an 18 month carcinogenicity study of DMA in p53 heterozygous (+/) knockout mice, which are susceptible to early spontaneous development of various types of tumors, and wild-type (+/+) C57BL/6J mice. Totals of 8890 males, 78 weeks of age, were divided into three groups each administered 0, 50 or 200 p.p.m. DMA in their drinking water for 18 months. Mice that were found moribund or died before the end of the study were autopsied to evaluate the tumor induction levels, as well as those killed at the end. Both p53+/ knockout and wild-type mice demonstrated spontaneous tumor development, but lesions were more prevalent in the knockout case. Carcinogenic effect of DMA was evident by significant early induction of tumors in both treated p53+/ knockout and wild-type mice, significant increase of the tumor multiplicity in 200 p.p.m.-treated p53+/ knockout mice, and by significant increase in the incidence and multiplicity of tumors (malignant lymphomas) in the treated wild-type mice. By the end of 80 weeks, tumor induction, particularly malignant lymphomas and sarcomas, were similar in treated and control p53+/ knockout mice. No evidence for organ-tumor specificity of DMA was obtained. Molecular analysis using PCRSSCP techniques revealed no p53 mutations in lymphomas from either p53+/ knockout or wild-type mice. In conclusion, DMA primarily exerted its carcinogenic effect on spontaneous development of tumors with both of the animal genotypes investigated here.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Z. Yu, C. V. Loehr, K. A. Fischer, M. A. Louderback, S. K. Krueger, R. H. Dashwood, N. I. Kerkvliet, C. B. Pereira, J. E. Jennings-Gee, S. T. Dance, et al. In utero Exposure of Mice to Dibenzo[a,l]Pyrene Produces Lymphoma in the Offspring: Role of the Aryl Hydrocarbon Receptor Cancer Res., January 15, 2006; 66(2): 755 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Waalkes, J. M. Ward, and B. A. Diwan Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers Carcinogenesis, January 1, 2004; 25(1): 133 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ide, M. Kitada, H. Sakashita, K. Kusama, K. Tanaka, and T. Ishikawa p53 Haploinsufficiency Profoundly Accelerates the Onset of Tongue Tumors in Mice Lacking the Xeroderma Pigmentosum Group A Gene Am. J. Pathol., November 1, 2003; 163(5): 1729 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, H. Wanibuchi, E. I. Salim, M. Wei, A. Kinoshita, K. Yoshida, G. Endo, and S. Fukushima Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats--association with oxidative DNA damage and enhanced cell proliferation Carcinogenesis, November 1, 2003; 24(11): 1827 - 1835. [Abstract] [Full Text] [PDF] |
||||


